“…The purpose of this bandage is that when applied to the skin, the skin rises, creating a space that contributes to the absorption of interstitial liquid and lymph flow [8,9,11,16]. The Kinesio ® Tex Gold bandage is composed of 100 % cotton material with acrylic glue and polyurethane that reacts to heat.…”
Section: Discussionmentioning
confidence: 99%
“…The application of the KT lymphatic method [9] was conducted by one independent physiotherapist. During the intervention with KT, the compression garment was removed.…”
Section: Methodsmentioning
confidence: 99%
“…In this sense, another approach currently discussed in secondary lymphedema after breast cancer is Kinesio ® Taping (KT) [5][6][7][8][9][10][11]. The tape is applied to the skin, and the area will form convolutions that lead to enlargement of the interstitial space, improving the absorption and the lymphatic flow [5,11].…”
Kinesio Tex Gold bandage by the KT technique proved to be safe and tolerable in patients with lymphedema, with improved functionality and no change of the affected limb volume.
“…The purpose of this bandage is that when applied to the skin, the skin rises, creating a space that contributes to the absorption of interstitial liquid and lymph flow [8,9,11,16]. The Kinesio ® Tex Gold bandage is composed of 100 % cotton material with acrylic glue and polyurethane that reacts to heat.…”
Section: Discussionmentioning
confidence: 99%
“…The application of the KT lymphatic method [9] was conducted by one independent physiotherapist. During the intervention with KT, the compression garment was removed.…”
Section: Methodsmentioning
confidence: 99%
“…In this sense, another approach currently discussed in secondary lymphedema after breast cancer is Kinesio ® Taping (KT) [5][6][7][8][9][10][11]. The tape is applied to the skin, and the area will form convolutions that lead to enlargement of the interstitial space, improving the absorption and the lymphatic flow [5,11].…”
Kinesio Tex Gold bandage by the KT technique proved to be safe and tolerable in patients with lymphedema, with improved functionality and no change of the affected limb volume.
“…These procedures are important to avoid influence on the treatment and to produce more consistent results 28 . All analyzed studies 1,[22][23][24][25][26][27] showed that intensive treatment with CDT favors volume reduction of the upper limb lymphedema. Pekyavas et al 22 investigated, through a randomized study, the effects of the association of CDT with neuromuscular elastic adhesive bandaging (KinesioTaping ® ) in patients with lymphedema.…”
Section: Discussionmentioning
confidence: 99%
“…22 Dayes et al 23 King at al. 24 Gurdal et al 1 Vignes et al 25 Vignes et al 26 Vignes et al 27 PEDro …”
IMPORTANCE Secondary lymphedema is a debilitating complication of breast cancer therapy and affects more than 1 in 5 breast cancer survivors. Patient-reported outcomes may be more important in predicting long-term health-related quality of life (HRQoL) than clinician-measured outcomes.OBJECTIVE To summarize published evidence on HRQoL outcomes for vascularized lymph node transfer (VLNT) and complex decongestive therapy (CDT) used in the treatment of breast cancer-related lymphedema.EVIDENCE REVIEW A literature search of PubMed/MEDLINE and Embase was conducted to identify articles on HRQoL in patients undergoing lymphedema treatment with CDT or VLNT published from January 1980 through April 2019. Studies using validated measurement instruments to assess HRQoL in patients with breast cancer-related lymphedema relative to baseline were included. This review is reported according to the PRISMA guidelines.FINDINGS A total of 16 articles were included in this review. Evidence regarding VLNT was reviewed from 2 studies involving 65 patients, and HRQoL was evaluated using the Lymphoedema Quality of Life Study questionnaire. Data on VLNT indicated favorable HRQoL outcomes at 12-month postoperative follow-up. Evidence regarding CDT was reviewed from 14 studies involving 569 patients, and HRQoL was evaluated using the 36-Item Short Form Health Survey, Functional Assessment of Cancer Therapy-Breast, European Organization for Research and Treatment of Cancer, and Functional Living Index-Cancer measures. Data on CDT demonstrated variable association with HRQoL, and a majority of articles reported improvement in at least 1 subscale. The use of diverse patient-reported outcome measures and variability in CDT protocol limited interpretation of results in this population and between treatment modalities.
CONCLUSIONS AND RELEVANCEAccording to this review, in deciding among breast cancer-related lymphedema treatment modalities, HRQoL outcomes are an important consideration that cannot be compared based on currently available data. Health-related quality-of-life outcomes obtained through coordinated use of preference-based health utility measures may be required to compare outcomes among patients undergoing surgical and nonsurgical treatments of breast cancer-related lymphedema. Additional studies are needed to better understand the best lymphedema treatment options and direct evidence-based care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.